(opens original source in a new tab)STAT NewsSTAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
(opens original source in a new tab)STAT NewsReduce protein to increase longevity? Nutrition experts say that’s a bad ideaReducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several reasons, experts say. (opens original source in a new tab)Lauren Chan·20 August 2026
(opens original source in a new tab)STAT NewsCan reclassifying muscle dysmorphia unlock better care for boys and men?Males make up about a third of the population struggling with eating disorders in the United States. While these conditions often start during the teen years, by some estimates, as… (opens original source in a new tab)Ashleigh N. DeLuca·20 August 2026
(opens original source in a new tab)STAT NewsSTAT+: How health systems are embracing chatbots to query and summarize patient recordsSeveral large health systems are rolling out AI chatbots to query patient records, because they can save time and increase diagnostic accuracy. (opens original source in a new tab)Katie Palmer·20 August 2026
(opens original source in a new tab)STAT NewsOpinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has Duchenne muscular dystrophy. (opens original source in a new tab)Mindy Leffler·20 August 2026
(opens original source in a new tab)STAT NewsSTAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDAIf she wins confirmation as FDA commissioner, Heidi Overton will face plenty of big challenges. (opens original source in a new tab)Chelsea Cirruzzo and Daniel Payne·19 August 2026
(opens original source in a new tab)STAT NewsSTAT+: New CDC director tells staff she is prepared to speak ‘truth to power’Then new CDC director told staff she is “very comfortable and very confident ... [in] speaking truth to power.” (opens original source in a new tab)Daniel Payne and Helen Branswell·19 August 2026
(opens original source in a new tab)STAT NewsTrust in science: A new STAT initiativeDear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver "trusted, tough-minded journalism.'' Little did we know that trust would be… (opens original source in a new tab)Rick Berke·19 August 2026
(opens original source in a new tab)STAT NewsSTAT+: Experts scrutinize Huidagene’s disclosures after patient deathMerck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout (opens original source in a new tab)Elaine Chen·19 August 2026
(opens original source in a new tab)STAT NewsSTAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approvalA Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval. (opens original source in a new tab)Andrew Joseph·19 August 2026
(opens original source in a new tab)STAT NewsSTAT+: American Cancer Society cancels alcohol industry fundraiserThe American Cancer Society had an optics problem: its annual Wine and Spirits Industry's Gala. It decided to do something about it. (opens original source in a new tab)Isabella Cueto·19 August 2026
(opens original source in a new tab)STAT NewsSTAT+: Brain organoids, kept alive more than five years, matured like human brainsBrain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic signatures like those of human brains. (opens original source in a new tab)Megan Molteni·19 August 2026